NASDAQ:GDRX GoodRx (GDRX) Stock Price, News & Analysis $3.46 -0.05 (-1.28%) As of 10:40 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About GoodRx Stock (NASDAQ:GDRX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GoodRx alerts:Sign Up Key Stats Today's Range$3.46▼$3.5050-Day Range$3.23▼$3.8052-Week Range$1.77▼$4.05Volume76,775 shsAverage Volume1.88 million shsMarket Capitalization$1.19 billionP/E Ratio86.65Dividend YieldN/APrice Target$4.23Consensus RatingHold Company Overview GoodRx Holdings, Inc. operates a healthcare technology platform that helps consumers find prescription medications at lower prices. Through its website and mobile applications, GoodRx allows users to compare prescription prices at participating pharmacies, access discount coupons and identify potential savings on commonly prescribed medications. The company’s services are primarily focused on the United States. GoodRx also offers GoodRx Gold, a membership program that provides additional discounts on eligible prescriptions, as well as telehealth services that connect consumers with healthcare providers for certain medical consultations and prescriptions. Its platform may also provide medication information, price comparisons and tools intended to support healthcare decision-making. In addition to its consumer offerings, GoodRx works with healthcare providers and pharmaceutical manufacturers through services designed to improve prescription access, affordability and patient engagement. The company was founded in 2011 by Trevor Bezdek, Doug Hirsch and Scott Marlette and became a publicly traded company on the Nasdaq under the symbol GDRX in 2020.AI Generated. May Contain Errors. Read More GoodRx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks84th Percentile Overall ScoreGDRX MarketRank™: 4.195349448235 of 5 starsGoodRx scored higher than 84% of companies evaluated by MarketBeat, and ranked 48th out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingHold Consensus RatingGoodRx has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on no strong buy ratings, 4 buy ratings, 6 hold ratings, and 3 sell ratings.Upside PotentialGoodRx has a consensus price target of $4.23, representing about 20.4% upside from its current price of $3.51.Amount of Analyst CoverageGoodRx has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about GoodRx's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth25.00% Earnings GrowthEarnings for GoodRx are expected to grow by 25.00% in the coming year, from $0.16 to $0.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of GoodRx is 87.77, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 36.53.Price to Earnings Ratio vs. SectorThe P/E ratio of GoodRx is 87.77, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 215.94.Price to Earnings Growth RatioGoodRx has a PEG Ratio of 1.68. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGoodRx has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about GoodRx's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.29% of the float of GoodRx has been sold short.Short Interest Ratio / Days to CoverGoodRx has a short interest ratio ("days to cover") of 5.37.Change versus previous monthShort interest in GoodRx has recently decreased by 12.07%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGoodRx does not currently pay a dividend.Dividend GrowthGoodRx does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment0.89 News SentimentGoodRx has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for GoodRx this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for GDRX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, GoodRx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,673,207.00 in company stock.Percentage Held by Insiders5.87% of the stock of GoodRx is held by insiders.Percentage Held by Institutions63.77% of the stock of GoodRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about GoodRx's insider trading history. Receive GDRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GDRX Stock News HeadlinesHead to Head Contrast: Definitive Healthcare (NASDAQ:DH) & GoodRx (NASDAQ:GDRX)October 14 at 3:45 AM | americanbankingnews.com3 reasons to avoid GDRX and 1 stock to buy insteadOctober 5, 2026 | msn.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 16 at 1:00 AM | Banyan Hill Publishing (Ad)Amazon, GoodRx target US prescription subscribers as health insurance coverage slipsSeptember 29, 2026 | reuters.comGoodRx Covers Whole Households and Pets in New Prescription PlanSeptember 4, 2026 | pymnts.comGoodRx offers health subscription for families, to launch as employee benefit in 2027September 3, 2026 | marketscreener.comMGoodRx offers health subscription for families, to launch as employee benefit in 2027September 3, 2026 | reuters.comAnalysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX)August 28, 2026 | theglobeandmail.comSee More Headlines GDRX Stock Analysis - Frequently Asked Questions How have GDRX shares performed this year? GoodRx's stock was trading at $2.71 on January 1st, 2026. Since then, GDRX shares have increased by 29.5% and is now trading at $3.51. How were GoodRx's earnings last quarter? GoodRx Holdings, Inc. (NASDAQ:GDRX) issued its earnings results on Wednesday, August, 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.00. GoodRx's revenue for the quarter was down 1.3% compared to the same quarter last year. Read the conference call transcript. When did GoodRx IPO? GoodRx (GDRX) raised $900 million in an initial public offering (IPO) on Wednesday, September 23rd 2020. The company issued 34,615,384 shares at $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays acted as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers. Who are GoodRx's major shareholders? GoodRx's top institutional investors include Krilogy Financial LLC. Insiders that own company stock include Scott Wagner, Francisco Partners Iv, LP and Equity Vii LP Spectrum. View institutional ownership trends. How do I buy shares of GoodRx? Shares of GDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GoodRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that GoodRx investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Tesla (TSLA), PayPal (PYPL), Block (XYZ), Teladoc Health (TDOC) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/05/2026Today10/16/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 GDRX's financial health is in the Green zone, according to TradeSmith. GDRX has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:GDRX CIK1809519 Webwww.goodrx.com Phone855-268-2822FaxN/AEmployees697Year Founded2011Price Target and Rating Average Price Target for GoodRx$4.23 High Price Target$5.00 Low Price Target$2.75 Potential Upside/Downside+22.0%Consensus RatingHold Rating Score (0-4)2.08 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$0.04 Trailing P/E Ratio86.65 Forward P/E Ratio21.66 P/E Growth1.68Net Income$30.44 million Net Margins2.07% Pretax Margin5.27% Return on Equity7.22% Return on Assets2.53% Debt Debt-to-Equity Ratio0.74 Current Ratio1.38 Quick Ratio1.38 Sales & Book Value Annual Sales$796.85 million Price / Sales1.49 Cash Flow$0.41 per share Price / Cash Flow8.45 Book Value$1.81 per share Price / Book1.91Miscellaneous Outstanding Shares342,570,000Free Float322,465,000Market Cap$1.19 billion OptionableOptionable Beta1.69 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:GDRX) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredMelting The GodsChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredMy next big call (under $1)Bitcoin is down. Fear is high. Most investors are sitting on their hands. That's exactly when my biggest winne...Crypto 101 Media | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
